MiMedx Group (MDXG) News Today $7.98 +0.13 (+1.66%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$7.98 -0.01 (-0.06%) As of 02/21/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period MiMedx Group (MDXG) Projected to Post Earnings on WednesdayMiMedx Group (NASDAQ:MDXG) will be releasing earnings after the market closes on Wednesday, February 26. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=662659)February 19 at 4:44 AM | marketbeat.comMiMedx Group Becomes Oversold (MDXG)February 13, 2025 | nasdaq.comMiMedx Group, Inc Common Stock (MDXG) Pre-MarketFebruary 11, 2025 | nasdaq.comMIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26February 5, 2025 | markets.businessinsider.comWhile shareholders of MiMedx Group (NASDAQ:MDXG) are in the black over 3 years, those who bought a week ago aren't so fortunateFebruary 5, 2025 | finance.yahoo.comMiMedx Group, Inc. (NASDAQ:MDXG) Shares Sold by Chicago Capital LLCChicago Capital LLC reduced its position in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 82.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 27,390 shares of the company's stock after selling 130February 4, 2025 | marketbeat.comSG Americas Securities LLC Has $802,000 Stock Holdings in MiMedx Group, Inc. (NASDAQ:MDXG)SG Americas Securities LLC grew its stake in MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 79.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 83,385 shares of the company's stock after buying an additional 37,031 shareJanuary 30, 2025 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Stock Price Up 5.8% - Time to Buy?MiMedx Group (NASDAQ:MDXG) Trading 5.8% Higher - Should You Buy?January 28, 2025 | marketbeat.comCraig-Hallum Keeps Their Buy Rating on MiMedx Group (MDXG)January 28, 2025 | markets.businessinsider.comMiMedx Group, Inc. (NASDAQ:MDXG) Receives Consensus Rating of "Buy" from AnalystsMiMedx Group, Inc. (NASDAQ:MDXG - Get Free Report) has been assigned an average rating of "Buy" from the five brokerages that are covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 12-month price target among brokerages thatJanuary 26, 2025 | marketbeat.comJPMorgan Chase & Co. Acquires 215,995 Shares of MiMedx Group, Inc. (NASDAQ:MDXG)JPMorgan Chase & Co. boosted its holdings in MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 265.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 297,367 shares of the company's stock after acquiring an additional 215,99January 23, 2025 | marketbeat.comCantor Fitzgerald Forecasts MiMedx Group FY2025 EarningsMiMedx Group, Inc. (NASDAQ:MDXG - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of MiMedx Group in a research note issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn anticipates that the company will post earnings per shareJanuary 22, 2025 | marketbeat.comBarclays PLC Buys 163,005 Shares of MiMedx Group, Inc. (NASDAQ:MDXG)Barclays PLC increased its stake in MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 163.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 262,449 shares of the company's stock after purchasing an additional 163,005 shaJanuary 13, 2025 | marketbeat.comMiMedx Group, Inc. (NASDAQ:MDXG) Given Average Recommendation of "Buy" by AnalystsShares of MiMedx Group, Inc. (NASDAQ:MDXG - Get Free Report) have received a consensus rating of "Buy" from the five analysts that are covering the company, MarketBeat.com reports. Five analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts thatJanuary 1, 2025 | marketbeat.comNorthland Capmk Forecasts MiMedx Group Q1 EarningsMiMedx Group, Inc. (NASDAQ:MDXG - Free Report) - Stock analysts at Northland Capmk issued their Q1 2025 EPS estimates for MiMedx Group in a research report issued on Friday, December 27th. Northland Capmk analyst C. Byrnes forecasts that the company will post earnings per share of $0.05 for the qDecember 30, 2024 | marketbeat.comMiMedx Group, Inc. (NASDAQ:MDXG) Shares Acquired by Barclays PLCBarclays PLC lifted its holdings in MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 163.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 262,449 shares of the company's stock after purchasing an additDecember 29, 2024 | marketbeat.comMiMedx Group, Inc. (NASDAQ:MDXG) Shares Acquired by Jane Street Group LLCJane Street Group LLC raised its stake in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 133.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 305,652 shares of the company's stock after buyingDecember 26, 2024 | marketbeat.comState Street Corp Lowers Position in MiMedx Group, Inc. (NASDAQ:MDXG)State Street Corp reduced its position in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 2.7% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,860,148 shares of the company's stock after selliDecember 23, 2024 | marketbeat.comMiMedx Files Against Patent Infringement Of Surgenexs's Placental Allograft ProductsDecember 18, 2024 | markets.businessinsider.comMIMEDX Files Patent Infringement Lawsuit Against SurgenexDecember 18, 2024 | markets.businessinsider.comCraig-Hallum Sticks to Their Buy Rating for MiMedx Group (MDXG)December 11, 2024 | markets.businessinsider.comCharles Schwab Investment Management Inc. Increases Position in MiMedx Group, Inc. (NASDAQ:MDXG)Charles Schwab Investment Management Inc. increased its stake in MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 6.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,435,397 shares of the company's stDecember 11, 2024 | marketbeat.comMiMedx Group, Inc. (NASDAQ:MDXG) Given Consensus Rating of "Buy" by AnalystsShares of MiMedx Group, Inc. (NASDAQ:MDXG - Get Free Report) have earned an average recommendation of "Buy" from the five ratings firms that are currently covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy recommendation. The average twelve-December 7, 2024 | marketbeat.comInstitutional investors own a significant stake of 43% in MiMedx Group, Inc. (NASDAQ:MDXG)December 2, 2024 | finance.yahoo.comMiMedx Group, Inc. (NASDAQ:MDXG) Position Lessened by Isthmus Partners LLCIsthmus Partners LLC reduced its stake in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 22.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 306,413 shares of theNovember 29, 2024 | marketbeat.comNorthland Securities Sticks to Its Buy Rating for MiMedx Group (MDXG)November 27, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and MiMedx Group (MDXG)November 17, 2024 | markets.businessinsider.comNorthland Securities Sticks to Their Buy Rating for MiMedx Group (MDXG)November 16, 2024 | markets.businessinsider.comMiMedx Group (NASDAQ:MDXG) Hits New 52-Week High - Should You Buy?MiMedx Group (NASDAQ:MDXG) Hits New 1-Year High - Here's What HappenedNovember 15, 2024 | marketbeat.comMiMedx provided update on LCDs regarding skin substituteNovember 14, 2024 | markets.businessinsider.comMIMEDX’s Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDsNovember 14, 2024 | markets.businessinsider.comMiMedx Group (NASDAQ:MDXG) Shares Gap Up - Here's WhyMiMedx Group (NASDAQ:MDXG) Shares Gap Up - What's Next?November 14, 2024 | marketbeat.comMIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDsNovember 14, 2024 | globenewswire.comMiMedx Group, Inc. (NASDAQ:MDXG) Given Average Rating of "Buy" by AnalystsMiMedx Group, Inc. (NASDAQ:MDXG - Get Free Report) has earned an average rating of "Buy" from the five research firms that are currently covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy rating. The average twelve-month price objective amNovember 12, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Stock Rating Lowered by StockNews.comStockNews.com downgraded MiMedx Group from a "strong-buy" rating to a "buy" rating in a research report on Friday.November 8, 2024 | marketbeat.comMiMedx Group's (NASDAQ:MDXG) Promising Earnings May Rest On Soft FoundationsNovember 7, 2024 | finance.yahoo.comHarbor Capital Advisors Inc. Boosts Holdings in MiMedx Group, Inc. (NASDAQ:MDXG)Harbor Capital Advisors Inc. increased its position in MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 299.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,027,738 shares of the cNovember 4, 2024 | marketbeat.comMiMedx Group FY2024 EPS Forecast Raised by Northland CapmkMiMedx Group, Inc. (NASDAQ:MDXG - Free Report) - Equities researchers at Northland Capmk upped their FY2024 earnings per share estimates for MiMedx Group in a note issued to investors on Thursday, October 31st. Northland Capmk analyst C. Byrnes now expects that the company will post earnings perNovember 4, 2024 | marketbeat.comMiMedx Group Third Quarter 2024 Earnings: Beats ExpectationsNovember 2, 2024 | finance.yahoo.comMiMedx Group, Inc: MIMEDX Announces Third Quarter 2024 Operating and Financial ResultsOctober 31, 2024 | finanznachrichten.deMiMedx Group Inc. Reports Q3 2024 Financial ResultsOctober 31, 2024 | markets.businessinsider.comCantor Fitzgerald Reaffirms Their Buy Rating on MiMedx Group (MDXG)October 31, 2024 | markets.businessinsider.comMiMedx Group (NASDAQ:MDXG) Shares Gap Up - Here's What HappenedMiMedx Group (NASDAQ:MDXG) Shares Gap Up - What's Next?October 31, 2024 | marketbeat.comMiMedx Group Reports 3% Sales Increase in Q3 2024October 31, 2024 | markets.businessinsider.comMiMedx Group Inc (MDXG) Q3 2024 Earnings Call Highlights: Strong International Growth and New ...October 31, 2024 | finance.yahoo.comMIMEDX Announces Third Quarter 2024 Operating and Financial ResultsOctober 30, 2024 | globenewswire.comCraig-Hallum Reaffirms Their Buy Rating on MiMedx Group (MDXG)October 28, 2024 | markets.businessinsider.comMDXG MiMedx Group, Inc.October 26, 2024 | seekingalpha.comMiMedx Group (MDXG) to Release Earnings on WednesdayMiMedx Group (NASDAQ:MDXG) will be releasing earnings after the market closes on Wednesday, October 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=635339)October 23, 2024 | marketbeat.comMiMedx Group, Inc. (NASDAQ:MDXG) Receives Consensus Rating of "Buy" from BrokeragesMiMedx Group, Inc. (NASDAQ:MDXG - Get Free Report) has earned an average recommendation of "Buy" from the five ratings firms that are covering the company, MarketBeat reports. Five research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers thaOctober 18, 2024 | marketbeat.com Get MiMedx Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address MDXG Media Mentions By Week MDXG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDXG News Sentiment▼0.000.60▲Average Medical News Sentiment MDXG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDXG Articles This Week▼13▲MDXG Articles Average Week Get MiMedx Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Inari Medical News Envista News PROCEPT BioRobotics News iRhythm Technologies News Warby Parker News LivaNova News Enovis News NovoCure News TransMedics Group News LeMaitre Vascular News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDXG) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiMedx Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiMedx Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
